Published in Arch Virol on January 01, 1998
Development of a real-time reverse-transcription PCR for detection of newcastle disease virus RNA in clinical samples. J Clin Microbiol (2004) 2.63
Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol (2001) 1.63
Pathotypical characterization and molecular epidemiology of Newcastle disease virus isolates from different hosts in China from 1996 to 2005. J Clin Microbiol (2007) 1.41
Newcastle disease virus in Madagascar: identification of an original genotype possibly deriving from a died out ancestor of genotype IV. PLoS One (2010) 1.38
Biological and phylogenetic characterization of pigeon paramyxovirus serotype 1 circulating in wild North American pigeons and doves. J Clin Microbiol (2008) 1.25
Phylogenetic analysis of Newcastle disease virus genotypes isolated in Japan. J Clin Microbiol (2002) 1.25
Herd immunity to Newcastle disease virus in poultry by vaccination. Avian Pathol (2008) 1.07
Genomic and biological characterization of a velogenic Newcastle disease virus isolated from a healthy backyard poultry flock in 2010. Virol J (2012) 1.05
Genotypic and pathotypic characterization of Newcastle disease viruses from India. PLoS One (2011) 1.03
Molecular epidemiology of outbreak-associated and wild-waterfowl-derived newcastle disease virus strains in Finland, including a novel class I genotype. J Clin Microbiol (2012) 0.97
New avian paramyxoviruses type I strains identified in Africa provide new outcomes for phylogeny reconstruction and genotype classification. PLoS One (2013) 0.93
Use of a heteroduplex mobility assay to detect differences in the fusion protein cleavage site coding sequence among Newcastle disease virus isolates. J Clin Microbiol (2001) 0.91
Molecular characterization and phylogenetic study of newcastle disease virus isolates from recent outbreaks in eastern Uganda. J Clin Microbiol (2004) 0.90
Characterization of a recombinant Newcastle disease virus vaccine strain. Clin Vaccine Immunol (2008) 0.89
Entire genome sequence analysis of genotype IX Newcastle disease viruses reveals their early-genotype phylogenetic position and recent-genotype genome size. Virol J (2011) 0.88
Variation of a newcastle disease virus hemagglutinin-neuraminidase linear epitope. J Clin Microbiol (2008) 0.88
Molecular characterization of avian paramyxovirus 1 isolates collected from cormorants in Canada from 1995 to 2000. J Clin Microbiol (2003) 0.86
Molecular epidemiology of Newcastle disease virus isolates from vaccinated commercial poultry farms in non-epidemic areas of Japan. Virol J (2013) 0.85
Orthomyxo-, paramyxo- and flavivirus infections in wild waterfowl in Finland. Virol J (2008) 0.85
Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy. Virol J (2011) 0.83
Lack of detection of host associated differences in Newcastle disease viruses of genotype VIId isolated from chickens and geese. Virol J (2012) 0.82
Velogenic Newcastle disease in imported caged birds. Can Vet J (2000) 0.80
Observation of risk factors, clinical manifestations and genetic characterization of recent Newcastle Disease Virus outbreak in West Malaysia. BMC Vet Res (2015) 0.79
Real-time PCR-based pathotyping of Newcastle disease virus by use of TaqMan minor groove binder probes. J Clin Microbiol (2009) 0.77
Characterization of emerging Newcastle disease virus isolates in China. Virol J (2015) 0.75
Genetic and biological characterizations of a Newcastle disease virus from swine in China. Virol J (2012) 0.75
Newcastle disease virus in pakistan: genetic characterization and implication in molecular diagnosis. Indian J Virol (2012) 0.75
Phylogenetic analysis of some Newcastle disease virus isolates from the Sudan. Open Vet J (2016) 0.75
The deletion of an extra six nucleotides in the 5' -untranslated region of the nucleoprotein gene of Newcastle disease virus NA-1 decreases virulence. BMC Vet Res (2014) 0.75
Comprehensive Analysis and Characterization of Linear Antigenic Domains on HN Protein from Genotype VII Newcastle Disease Virus Using Yeast Surface Display System. PLoS One (2015) 0.75
Antigenic and immunogenic investigation of the virulence motif of the Newcastle disease virus fusion protein. J Vet Sci (2010) 0.75
Phylogenetic assessment reveals continuous evolution and circulation of pigeon-derived virulent avian avulaviruses 1 in Eastern Europe, Asia, and Africa. BMC Vet Res (2017) 0.75
Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Arch Virol (2001) 3.78
Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol (1999) 3.74
Isolation and characterization of a hepatitis B virus endemic in herons. J Virol (1988) 3.23
Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie. J Gen Virol (1995) 2.55
Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus. Virology (1975) 2.55
Synthesis of Rauscher murine leukemia virus-specific polypeptides in vitro. Proc Natl Acad Sci U S A (1976) 2.36
Phylogenetic analyses of highly pathogenic avian influenza virus isolates from Germany in 2006 and 2007 suggest at least three separate introductions of H5N1 virus. Vet Microbiol (2007) 2.34
The US3-encoded protein kinase from pseudorabies virus affects egress of virions from the nucleus. J Gen Virol (1995) 2.04
Virus-specific messenger RNA on free and membrane-bound polyribosomes from cells infected with Rauscher leukemia virus. Proc Natl Acad Sci U S A (1974) 1.93
Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity. J Gen Virol (1992) 1.90
Two novel genetic groups (VIIb and VIII) responsible for recent Newcastle disease outbreaks in Southern Africa, one (VIIb) of which reached Southern Europe. Arch Virol (1999) 1.88
Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J (1995) 1.82
Studies of in vivo distribution of bovine herpesvirus type 4 in the natural host. J Clin Microbiol (1996) 1.70
Type- and subtype-specific RT-PCR assays for avian influenza A viruses (AIV). J Vet Med B Infect Dis Vet Public Health (2000) 1.65
Identification and grouping of Newcastle disease virus strains by restriction site analysis of a region from the F gene. Arch Virol (1996) 1.49
Antigenic and genetic analyses of isolate APMV/wigeon/Italy/3920-1/2005 indicate that it represents a new avian paramyxovirus (APMV-12). Arch Virol (2013) 1.49
A simple method for the purification of 5-aminosalicylic acid. Application of the product as substrate in enzyme-linked immunosorbent assay (ELISA). J Immunol Methods (1980) 1.48
Identification of Rauscher murine leukemia virus-specific mRNAs for the synthesis of gag- and env-gene products. Proc Natl Acad Sci U S A (1977) 1.43
Repeats in an extracellular protein of weakly pathogenic strains of Streptococcus suis type 2 are absent in pathogenic strains. Infect Immun (1993) 1.43
Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res (1997) 1.42
Uncompensated blood loss is not tolerated during acute normovolemic hemodilution in anesthetized pigs. Anesth Analg (1998) 1.42
Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muramidase-released protein) of Streptococcus suis type 2. Infect Immun (1992) 1.38
Epidemiological and ornithological aspects of outbreaks of highly pathogenic avian influenza virus H5N1 of Asian lineage in wild birds in Germany, 2006 and 2007. Transbound Emerg Dis (2009) 1.37
High-efficiency transformation and gene inactivation in Streptococcus suis type 2. Microbiology (1995) 1.36
Genome differences among field isolates and vaccine strains of pseudorabies virus. J Gen Virol (1985) 1.35
Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. J Virol (1989) 1.30
Cytolysins of Actinobacillus pleuropneumoniae serotype 9. Infect Immun (1991) 1.29
Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1). Euro Surveill (2014) 1.27
Genome replication of Newcastle disease virus: involvement of the rule-of-six. Arch Virol (2000) 1.25
Evidence of West Nile virus lineage 2 circulation in Northern Italy. Vet Microbiol (2012) 1.25
An indirect enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to maedi-visna virus. Vet Microbiol (1982) 1.25
Identification and analysis of a new hepadnavirus in white storks. Virology (2001) 1.24
Confirmation of H5N1 avian influenza in Africa. Vet Rec (2006) 1.23
Infectious bursal disease (Gumboro disease). Rev Sci Tech (2000) 1.22
Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor. Mol Cell Biol (1999) 1.21
A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine (1994) 1.21
The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus. Vet Microbiol (1984) 1.20
Ultrastructural changes of the tracheal epithelium after vaccination of day-old chickens with the La Sota strain of Newcastle disease virus. Vet Pathol (2005) 1.18
The positively charged structural virus protein (VP1) of foot-and-mouth disease virus (type O1) contains a highly basic part which may be involved in early virus-cell interaction. J Gen Virol (1982) 1.18
Emergence of a new genetic lineage of Newcastle disease virus in West and Central Africa--implications for diagnosis and control. Vet Microbiol (2009) 1.17
Identification of sensitive and specific avian influenza polymerase chain reaction methods through blind ring trials organized in the European Union. Avian Dis (2007) 1.17
Recent influenza A (H1N1) infections of pigs and turkeys in northern Europe. Virology (1994) 1.15
Deleting two amino acids in glycoprotein gI of pseudorabies virus decreases virulence and neurotropism for pigs, but does not affect immunogenicity. J Gen Virol (1993) 1.15
Detection of Mycobacterium avium subsp. paratuberculosis in tissue samples by single, fluorescent and nested PCR based on the IS900 gene. Vet Microbiol (2001) 1.15
Comparative pathogenesis of three strains of pseudorabies virus in pigs. Microb Pathog (1989) 1.14
Interactions in vivo between the proteins of infectious bursal disease virus: capsid protein VP3 interacts with the RNA-dependent RNA polymerase, VP1. J Gen Virol (2000) 1.13
Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine (2001) 1.13
Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. J Gen Virol (1989) 1.12
Comparison of three rapid detection systems for type A influenza virus on tracheal swabs of experimentally and naturally infected birds. Avian Pathol (2004) 1.12
Phylogenetic analysis of rabbit haemorrhagic disease and European brown hare syndrome viruses by comparison of sequences from the capsid protein gene. Arch Virol (1997) 1.11
Establishment of a competitive ELISA (cELISA) system for the detection of influenza A virus nucleoprotein antibodies and its application to field sera from different species. J Vet Med B Infect Dis Vet Public Health (2006) 1.10
An analyzer for in-line measurement of expiratory sulfur hexafluoride concentration. Anesthesiology (1985) 1.09
Cloning and characterization of the Actinobacillus pleuropneumoniae-RTX-toxin III (ApxIII) gene. Infect Immun (1993) 1.09
Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils. Infect Immun (1995) 1.09
Molecular-biological characterization of Marek's disease virus. I. Identification of virus-specific polypeptides in infected cells. Virology (1982) 1.09
Experiences on the application of the polymerase chain reaction in a diagnostic laboratory. Mol Cell Probes (1993) 1.09
Emergence of fox rabies in north-eastern Italy. Euro Surveill (2008) 1.08
An efficient procedure for the isolation of polyribosomes from tissue culture. Eur J Biochem (1971) 1.07
Neurotropism of highly pathogenic avian influenza virus A/chicken/Indonesia/2003 (H5N1) in experimentally infected pigeons (Columbia livia f. domestica). Vet Pathol (2006) 1.06
Polymerase chain reaction combined with restriction enzyme analysis for detection and differentiation of fowl adenoviruses. Avian Pathol (2001) 1.06
Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity. J Virol (1986) 1.06
A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J Gen Virol (1994) 1.05
Ventilation inhomogeneity during controlled ventilation. Which index should be used? J Appl Physiol (1985) (1988) 1.05
Inactivation of avian influenza viruses by chemical agents and physical conditions: a review. Zoonoses Public Health (2007) 1.05
Structural analysis of the Actinobacillus pleuropneumoniae-RTX-toxin I (ApxI) operon. Infect Immun (1993) 1.04
Rescue of very virulent and mosaic infectious bursal disease virus from cloned cDNA: VP2 is not the sole determinant of the very virulent phenotype. J Virol (2000) 1.04
Some characteristics of four attenuated vaccine virus strains and a virulent strain of Aujeszky's disease virus. Vet Q (1984) 1.03
Acute infectious bursal disease in poultry: Isolation and characterisation of a highly virulent strain. Avian Pathol (1991) 1.02
Isolation and characterization of trypsin-resistant O1 variants of foot-and-mouth disease virus. J Gen Virol (1979) 1.02
Deleting valine-125 and cysteine-126 in glycoprotein gI of pseudorabies virus strain NIA-3 decreases plaque size and reduces virulence in mice. Arch Virol (1993) 1.00
Clinical, gross, and microscopic findings in different avian species naturally infected during the H7N1 low- and high-pathogenicity avian influenza epidemics in Italy during 1999 and 2000. Avian Dis (2003) 0.99
Differentiation between enzootic and sporadic bovine leukosis by use of serological and virological methods. Vet Rec (1993) 0.98
Comparative pathogenicity study of ten different betanodavirus strains in experimentally infected European sea bass, Dicentrarchus labrax (L.). J Fish Dis (2013) 0.97
Efficient rescue of infectious bursal disease virus from cloned cDNA: evidence for involvement of the 3'-terminal sequence in genome replication. Virology (1999) 0.97
Highly pathogenic avian influenza H5N1 subtype in mute swans in Italy. Vet Rec (2006) 0.96
Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals. Avian Dis (2007) 0.95
Comparison of the genomes of 15 avian herpes-virus isolates by restriction endonuclease analysis. Avian Pathol (1997) 0.95
Evaluation of the use of monoclonal antibodies to hemagglutinin and fusion glycoproteins of Newcastle disease virus for virus identification and strain differentiation purposes. Arch Virol (1987) 0.95
Functional residual capacity and ventilation homogeneity in mechanically ventilated small neonates. J Appl Physiol (1985) (1992) 0.95
Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J Gen Virol (1990) 0.94
Control of avian influenza in Italy: from stamping out to emergency and prophylactic vaccination. Dev Biol (Basel) (2006) 0.94
Single PCR and nested PCR with a mimic molecule for detection of Mycobacterium avium subsp. paratuberculosis. Diagn Microbiol Infect Dis (1999) 0.94
Field experiences in the control of avian influenza outbreaks in densely populated poultry areas. Dev Biol (Basel) (2004) 0.94
The occurrence of five major Newcastle disease virus genotypes (II, IV, V, VI and VIIb) in Bulgaria between 1959 and 1996. Epidemiol Infect (2002) 0.94
Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Crit Care Med (1993) 0.94
Experimental infection of ostriches with Crimean-Congo haemorrhagic fever virus. Epidemiol Infect (1998) 0.93
Monitoring for highly pathogenic avian influenza in wild birds in Italy. Vet Rec (2000) 0.93
Epitope analysis of glycoprotein I of pseudorabies virus. J Gen Virol (1990) 0.93
Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease. Vet Microbiol (1990) 0.92
Efficacy of some disinfectants against infectious bursal disease virus and avian reovirus. Vet Rec (1982) 0.91
Application of the polymerase chain reaction (PCR) in veterinary diagnostic virology. Vet Res Commun (1993) 0.91
A virological survey in migrating waders and other waterfowl in one of the most important resting sites of Germany. J Vet Med B Infect Dis Vet Public Health (2006) 0.91
Molecular-biological characterization of Marek's disease virus. II. Differentiation of various MDV and HVT strains. Virology (1982) 0.91
Genetic map of the Actinobacillus pleuropneumoniae RTX-toxin (Apx) operons: characterization of the ApxIII operons. Infect Immun (1994) 0.91
Fusion (F) protein gene of Newcastle disease virus: sequence and hydrophobicity comparative analysis between virulent and avirulent strains. Virus Genes (1988) 0.91